ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $537,400 | -24.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $713,200 | +47.8% | 20,000 | +5.3% | 0.00% | 0.0% |
Q1 2023 | $482,600 | -37.4% | 19,000 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $770,640 | +22.7% | 19,000 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $628,000 | -6.1% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $669,000 | -23.5% | 19,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $874,000 | -30.6% | 19,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,260,000 | +6.2% | 19,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,186,000 | -24.7% | 19,000 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $1,574,000 | -5.1% | 19,000 | -24.0% | 0.00% | 0.0% |
Q1 2021 | $1,658,000 | -13.6% | 25,000 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $1,918,000 | +78.3% | 25,000 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $1,076,000 | -0.4% | 25,000 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $1,080,000 | +134.8% | 25,000 | +56.2% | 0.00% | +50.0% |
Q1 2020 | $460,000 | -54.7% | 16,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $1,015,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,328 | $51,213,000 | 30.37% |
JOHNSON & JOHNSON | 3,260,869 | $203,576,000 | 17.86% |
ACT CAPITAL MANAGEMENT, LLC | 194,000 | $12,111,000 | 6.28% |
Aquilo Capital Management, LLC | 527,926 | $32,958,000 | 5.99% |
Evolutionary Tree Capital Management, LLC | 105,491 | $6,586,000 | 2.92% |
ACUTA CAPITAL PARTNERS, LLC | 121,500 | $7,585,000 | 2.68% |
L1 Capital Pty Ltd | 297,915 | $18,599,000 | 2.31% |
Avidity Partners Management LP | 673,700 | $42,059,000 | 0.93% |
Hood River Capital Management LLC | 338,734 | $21,147,000 | 0.65% |
Tygh Capital Management, Inc. | 64,127 | $4,003,000 | 0.54% |